Top compounds associated with response to DDB2


Feature Type Standardized
Nominal ANOVA
mRNA Erlotinib gCSI pan-cancer AAC 0.12 0.03
mRNA KIN001-055 GDSC1000 pan-cancer AAC 0.074 0.04
mRNA CD-1530 CTRPv2 pan-cancer AAC 0.081 0.04
mRNA Curcumin CTRPv2 pan-cancer AAC 0.072 0.04
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.072 0.04
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.075 0.04
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.073 0.04
mRNA BRD-K17060750 CTRPv2 pan-cancer AAC 0.078 0.04
mRNA Crizotinib CTRPv2 pan-cancer AAC 0.067 0.04
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.059 0.04
Download CSV